EPHX2 and schizophrenia: Finally, the potent sEH inhibitor AS2586114 improved schizophrenia-like behavioral abnormalities (e.g., hyperlocomotion and pre-pulse inhibition deficits) in a sample of phencyclidine (PCP)-treated mice, suggesting that sEH inhibitor might have antipsychotic-like activity [87].